Status: Recruiting
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
The purpose of this study is to evaluate the long-term safety and tolerability of KarXT and KarX-EC for the treatment of Schizophrenia and autism-related irritability in adolescents, respectively
Participants needed: 400
Trial details
Phase: Phase 3Age: 5-17Biological sex: AllType: InterventionalSponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb companyUpdated: Jun 23, 2026Locations: 58
Eligibility criteria
Participants must not have a significant risk of committing violent acts, seriou... [+3]